{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:33:02Z","timestamp":1787578382965,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd011330","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000}}],"reference-count":66,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011330.pub2","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T06:36:42Z","timestamp":1749537402000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS)"],"prefix":"10.1002","volume":"2025","author":[{"given":"Bushra","family":"Naheed","sequence":"additional","affiliation":[{"name":"Institute for Science and Technology in Medicine; Keele University; Stoke-on-Trent UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Herman","family":"Kuiper","sequence":"additional","affiliation":[{"name":"Institute for Science and Technology in Medicine; Keele University; Stoke-on-Trent UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidelma","family":"O'Mahony","sequence":"additional","affiliation":[{"name":"Academic Unit of Obstetrics and Gynaecology; University Hospitals of North Midlands; Stoke-on-Trent UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick MS","family":"O'Brien","sequence":"additional","affiliation":[{"name":"School of Medicine; Keele University; Keele UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"10.1002\/14651858.CD011330.pub2-BIB0001|cit1","first-page":"779\u201386","article-title":"Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial","volume":"84","author":"Brown","year":"1994","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0002|cit2","first-page":"380\u20134","article-title":"Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome","volume":"75","author":"DiCarlo","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2265.2003.01911.x","article-title":"Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone","volume":"59","author":"Tommaselli","year":"2003","journal-title":"Clinical Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0004|cit4","first-page":"303\u20139","article-title":"Gonadotrophin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study","volume":"33","author":"Freeman","year":"1997","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00016348809004191","article-title":"Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo","volume":"67","author":"Hammarback","year":"1988","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD011330.pub2-BIB0006|cit6","first-page":"864","article-title":"Premenstrual-syndrome and related hormonal changes - long-acting gonadotropin-releasing-hormone agonist treatment","volume":"38","author":"Helvacioglu","year":"1993","journal-title":"Journal of Reproductive Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011330.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/09513599209081007","article-title":"Buserelin in premenstrual-syndrome","volume":"6","author":"Hussain","year":"1992","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD011330.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/09513599909167531","article-title":"The treatment of severe premenstrual syndrome with goserelin with and without \u2018add-back\u2019 estrogen therapy: a placebo-controlled study","volume":"13","author":"Leather","year":"1999","journal-title":"Gynecological Endocrinology"},{"issue":"212","key":"10.1002\/14651858.CD011330.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM198411223112104","article-title":"The premenstrual syndrome: effects of medical ovariectomy","volume":"311","author":"Muse","year":"1984","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011330.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome","volume":"338","author":"Schmidt","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2009.06.001","article-title":"Discussion: 'Add-back regimens in patients using a GnRH agonist for premenstrual dysphoric disorder' by Segebladh et al","volume":"201","author":"Jungheim","year":"2009","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"139","key":"10.1002\/14651858.CD011330.pub2-BIB0012|cit12","first-page":"e1","article-title":"Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder","volume":"201","author":"Segebladh","year":"2009","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0013|cit13","unstructured":"Sundstr\u00f6m-Poromaa I Your 2009 trial on add-back regimens for GnRH agonists [personal communication] Email (with anonymised data) to: JH Kuiper"},{"issue":"10","key":"10.1002\/14651858.CD011330.pub2-BIB0014|cit14","first-page":"891\u20139","article-title":"Treatment of premenstrual syndrome with gonadotrophin releasing hormone agonist in a low dose regimen","volume":"78","author":"Sundstrom","year":"1999","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2265.1987.tb01142.x","article-title":"The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes","volume":"27","author":"Bancroft","year":"1987","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"932\u20137","DOI":"10.1016\/S0015-0282(16)57053-8","article-title":"Depot leuprolide acetate with estrogen and progestin addback for long term treatment of premenstrual syndrome","volume":"62","author":"Mezrow","year":"1994","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"252A","DOI":"10.1210\/jcem-72-2-252","article-title":"Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing hormone agonist and estrogen\/progestin","volume":"72","author":"Mortola","year":"1991","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2017.16101113","article-title":"Exposure to a change in ovarian steroid levels but not continuous stable levels triggers PMDD symptoms following ovarian suppression","volume":"174","author":"Schmidt","year":"2017","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1058\u201363","DOI":"10.1093\/oxfordjournals.humrep.a138633","article-title":"Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of premenstrual syndrome","volume":"9","author":"West","year":"1994","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD011330.pub2-BIB0020|cit20","first-page":"446","article-title":"Nutritional factors in the etiology of the premenstrual tension syndromes","volume":"28","author":"Abraham","year":"1983","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuroscience.2011.03.061","article-title":"Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons","volume":"191","author":"B\u00e4ckstr\u00f6m","year":"2011","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD011330.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jad.2015.08.063","article-title":"Daily symptom ratings for studying premenstrual dysphoric disorder: a review","volume":"189","author":"Bosman","year":"2016","journal-title":"Journal of Affective Disorders."},{"issue":"5","key":"10.1002\/14651858.CD011330.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200317050-00003","article-title":"The role of hormones and hormonal treatments in premenstrual syndrome","volume":"17","author":"B\u00e4ckstr\u00f6m","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0026|cit26","unstructured":"American Psychiatric Association DSM-IV-TR Diagnostic and Statistical Manual of Mental Disorders 5th edition (text revision) 2000"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0027|cit27","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, DSM-5","author":"American Psychiatric Association","year":"2013"},{"issue":"3","key":"10.1002\/14651858.CD011330.pub2-BIB0028|cit28","first-page":"109","article-title":"Retrospective report of premenstrual depressive changes: factors affecting confirmation by daily ratings","volume":"18","author":"Endicott","year":"1982","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"41\u20139","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily Record of Severity of Problems (DRSP): reliability and validity","volume":"9","author":"Endicott","year":"2006","journal-title":"Archives of Women's Mental Health"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0165-1781(96)02929-0","article-title":"Reliability and validity of a daily diary for premenstrual syndrome","volume":"65","author":"Freeman","year":"1996","journal-title":"Psychiatry Research"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0031|cit31","first-page":"85","article-title":"Premenstrual syndrome","volume":"54","author":"Gianetto-Berruti","year":"2002","journal-title":"Minerva Ginecologica"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0032|cit32","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/070674378503000706","article-title":"The clinical diagnosis and classification of premenstrual changes","volume":"30","author":"Halbreich","year":"1985","journal-title":"Canadian Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011330.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0022-3999(02)00297-0","article-title":"Assessing the assessment measures for menstrual cycle symptoms: a guide for researchers and clinicians","volume":"52","author":"Haywood","year":"2002","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0036|cit36","unstructured":"Higgins JPT Altman DG Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane 2017 Available from https:\/\/training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0037|cit37","unstructured":"Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD011330.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","article-title":"Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus","volume":"14","author":"O'Brien","year":"2011","journal-title":"Archives of Women's Mental Health"},{"issue":"4","key":"10.1002\/14651858.CD011330.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00737-013-0346-y","article-title":"ISPMD consensus on the management of premenstrual disorders","volume":"16","author":"Nevatte","year":"2013","journal-title":"Archives of Women's Mental Health"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0040|cit40","first-page":"27","article-title":"The epidemiology of premenstrual syndrome","volume":"11","author":"Johnson","year":"2004","journal-title":"Primary Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD011330.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3949\/ccjm.71.4.303","article-title":"Premenstrual dysphoric disorder: a review for the treating practitioner","volume":"71","author":"Kaur","year":"2004","journal-title":"Cleveland Clinic Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1365-2265.2002.01291.x","article-title":"Clinical use of GnRH analogues","volume":"56","author":"Kiesel","year":"2002","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0043|cit43","first-page":"53","article-title":"The neuroendocrine control of the menstrual cycle","volume":"36","author":"Knobil","year":"1980","journal-title":"Recent Progress in Hormone Research"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/humrep\/deae081","article-title":"Global, regional, and national burden of premenstrual syndrome, 1990-2019: an analysis based on the Global Burden of Disease Study 2019","volume":"39","author":"Liu","year":"2024","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006586.pub4","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","author":"Lopez","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0046|cit46","first-page":"80","article-title":"Premenstrual syndrome","volume":"1","author":"Magos","year":"1988","journal-title":"Contemporary Reviews in Obstetrics and Gynaecology"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0047|cit47","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001396.pub3","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","author":"Marjoribanks","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1258\/0007142001903346","article-title":"Progress towards the development of non-peptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications","volume":"56","author":"Millar","year":"2000","journal-title":"British Medical Bulletin"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"105996","DOI":"10.1016\/j.jddst.2024.105996","article-title":"Long acting injectables for the treatment of prostate cancer","volume":"100","author":"Modi","year":"2024","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD011330.pub2-BIB0051|cit51","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010503.pub2","article-title":"Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome","author":"Naheed","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011330.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Medical Care"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0053|cit53","first-page":"401","volume-title":"Gynaecology","author":"O'Brien","year":"2003"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0054|cit54","doi-asserted-by":"crossref","DOI":"10.3109\/9781435628168","volume-title":"The Premenstrual Syndromes","author":"O'Brien","year":"2007"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"d2994","DOI":"10.1136\/bmj.d2994","article-title":"Diagnosis and management of premenstrual disorders","volume":"342","author":"O'Brien","year":"2011","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD011330.pub2-BIB0056|cit56","first-page":"50","article-title":"Premenstrual syndrome: making sense of the options","volume":"65","author":"Panay","year":"2004","journal-title":"Pulse"},{"issue":"5","key":"10.1002\/14651858.CD011330.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/GCO.0b013e3283094b79","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder in adolescents","volume":"20","author":"Rapkin","year":"2008","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0058|cit58","unstructured":"Green LJ O\u2019Brien PMS Panay N Craig M on behalf of the Royal College of Obstetricians and Gynaecologists Management of premenstrual syndrome BJOG 2017 124 e73\u2013e105"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0059|cit59","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2024"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/ebm.1996.1.164","article-title":"Down with odds ratios!","volume":"1","author":"Sackett","year":"1996","journal-title":"Evidence Based Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00006842-198312000-00003","article-title":"Mood, sexuality, hormones and the menstrual cycle. I. Changes in mood and physical state: description of subjects and method","volume":"45","author":"Sanders","year":"1983","journal-title":"Psychosomatic Medicine"},{"key":"10.1002\/14651858.CD011330.pub2-BIB0062|cit62","volume-title":"State-trait Anxiety Inventory for Adults: Manual and Sample: Manual, Instrument and Scoring Guide","author":"Spielberger","year":"1983"},{"issue":"2","key":"10.1002\/14651858.CD011330.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0447.1980.tb00605.x","article-title":"Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales","volume":"62","author":"Steiner","year":"1980","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2265.2003.01911.x","article-title":"Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone","volume":"59","author":"Tommaselli","year":"2003","journal-title":"Clinical Endocrinology"},{"issue":"6","key":"10.1002\/14651858.CD011330.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis","volume":"111","author":"Wyatt","year":"2004","journal-title":"BJOG"},{"issue":"10","key":"10.1002\/14651858.CD011330.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011330","article-title":"Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS)","author":"Naheed","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:02:48Z","timestamp":1772409768000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011330.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":66,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011330.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}